Merger Arb Mondays (26 May) - Mayne, Seven & I, Shibaura, Welcia/Tsuruha, Nissin, ESR, Dickson
We summarise the latest spreads and newsflow of merger arb situations we cover across Hong Kong, Australia, New Zealand, Singapore, Japan,...
569 Views
Mayne Pharma (MYX AU): A Case of Buyer’s Remorse
Precedent schemes suggest a lower offer is the best-case scenario. An unwilling bidder looking for angles, contractually, to exit suggests the...
882 Views
Mayne Pharma (MYX AU): Scheme Booklet Dispatch Lends More Than A Veneer Of Support
Mayne, ASIC AND Cosette have effectivelty signed off on the Doc's veracity. Trading at a whopping 19.4%/295% gross/annualised spread. I would buy...
436 Views
Mayne Pharma (MYX AU): The Scheme Booklet Should Calm Nerves
The scheme booklet should reassure that Cosette is not contesting the MAC clause. Recent events should help quell previous retail opposition to the...
657 Views
Mayne Pharma (MYX AU): Firm Support From Cosette Would Be Welcome About Now
The FDA letter does not appear a material issue. And shares (before the open) are just 6% above undisturbed levels. On balance, this is a buy. A...
598 Views